Pharmaceutical Accountability
Cross-source consensus on Pharmaceutical Accountability from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Risks & contraindications
Interactions
Highlighted claims
- Pharmaceutical fines may be treated as a cost of doing business when profits remain larger. — Big Pharma and the Corruption of Medical Knowledge
- The article argues that current penalties do not adequately deter pharmaceutical misconduct. — Big Pharma and the Corruption of Medical Knowledge
- The article argues that pharmaceutical lobbying power protects the existing system. — Big Pharma and the Corruption of Medical Knowledge
- Criminal liability for senior executives is described as rare even when companies commit felonies or many people are harmed. — Big Pharma and the Corruption of Medical Knowledge
- The article connects pharmaceutical political influence to resistance against Medicare drug price negotiation. — Big Pharma and the Corruption of Medical Knowledge